Examination Report |
1 | Additional Representation Sheet | 20 Dec 2011 |
1 | TM-1 | 20 Dec 2011 |
10 | Hearing Notice | 12 Jan 2024 |
11 | Hearing Notice | 05 Mar 2024 |
2 | Additional Representation Sheet | 20 Dec 2011 |
2 | TM-1 | 20 Dec 2011 |
3 | Reply to Exam Report (MIS-R) | 01 Sep 2014 |
4 | Reply to Exam Report (MIS-R) | 05 Sep 2014 |
5 | TM-5 | 16 Jun 2016 |
6 | Forwarding Letter for TM-5 | 25 Jul 2016 |
7 | Journal Copy | 19 Aug 2016 |
8 | Forwarding Letter for TM-6 | 16 Dec 2016 |
9 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 17 Jul 2023 |
1 | Opposition Counter Statement | 4170832 | 03 Nov 2016 |
The application for Bromezer was made on 20 December 2011.
The trademark applicant for Bromezer is REGENIX DRUGS.
Bromezer is applied in class(es) 5.
Application for Bromezer is on Opposed stage.
Application Id allotted to Bromezer is 2253019.
Trademark agent or attorney for the application is Senthil Kumar Balakrishnan.
Bromezer filed with the Intellectual property office as a WORD.